PuSH - Publikationsserver des Helmholtz Zentrums München

Gasparin, F. ; Tietje, M.R.* ; Katab, E.* ; Nurdinova, A. ; Yuan, T. ; Chmyrov, A. ; Uluc, N. ; Jüstel, D. ; Bassermann, F.* ; Ntziachristos, V. ; Pleitez, M.A.

Label-free protein-structure-sensitive live-cell microscopy for patient-specific assessment of myeloma therapy.

Nat. Bio. Eng., DOI: 10.1038/s41551-025-01443-3 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
The efficacy of drug therapy in multiple myeloma is conventionally assessed by whole-cell-population methods, serum analysis of light chains and monoclonal antibodies, immunofixation electrophoresis, or by flow cytometry of bone marrow aspirates and biopsies. These methods provide relevant information on the presence of specific immunoglobulins at high sensitivity and specificity but require a large number of cells, involve long and laborious sample preparation steps, and provide only tumour bulk information. Here we develop a single-cell imaging technique requiring a reduced number of primary cells for longitudinal evaluation of patient-specific treatment and assessment of treatment heterogeneity. By exploiting the mechanistic action of proteasome inhibition and in synergy with the label-free protein-structure specificity of mid-infrared optoacoustic microscopy, we present a technology that facilitates longitudinal evaluation of myeloma treatment and a patient's heterogeneous response. Detecting optical-generated ultrasound waves that intensify with optical absorption, this technology allows observation of proteins in living cells with high sensitivity. Specifically, we use intermolecular β-sheet formation as a biomarker for cell viability during therapy and apply it to assess drug-treatment performance in multiple myeloma patients.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Human Multiple-myeloma; Infrared-spectroscopy; Proteasome Inhibitors; Ir; Conformation; Bortezomib; Apoptosis
ISSN (print) / ISBN 2157-846X
e-ISSN 2157-846X
Zeitschrift Nature biomedical engineering
Verlag Nature Publishing Group
Verlagsort London ; New York NY ; Tokyo
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Biological and Medical Imaging (IBMI)
Institute of Computational Biology (ICB)
Förderungen European Research Council (ERC) under the European Union
German Research Foundation)
Deutsche Forschungsgemeinschaft (DFG
Deutsche Forschungsgemeinschaft (German Research Foundation)